Biểu đồ giá cổ phiếu QURE
QURE Thu nhập
Uniqure NV
$46.29
-3.88%
$-1.86
Khi đóng cửa: Jun 18, 16:00:00 GMT-4
$46.5
0.45%
$0.21
Phiên sau giờ: Jun 18, 20:00:00 GMT-4
Quay lại
Uniqure NV (QURE) Thu nhập
Thống kê chính
Giá đóng cửa trước
$48.16
Giá mở cửa
$48.87
Phạm vi ngày
$45.77 - $50.08
Phạm vi 52 tuần
$8.73 - $71.5
Khối lượng
4.3M
Khối lượng trung bình
2.8M
Tỷ suất cổ tức
--
EPS (TTM)
-3.51
Vốn hóa thị trường
$2.9B
QURE là gì?
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. The company employs 221 full-time employees The company went IPO on 2014-02-05. The company seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. The company develops, both internally and through partnerships, a pipeline of gene therapies. The company produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
